Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: alpha-synuclein

November 11, 2024 CD as API / Pharma applications

The role of gut in Parkinson’s disease

The role of gut in development of Parkinson’s disease has been long suspected as constipation appears years before the typical

Continue reading

January 11, 2024 Drug delivery / Pharma applications

Alpha-synuclein misfolding inhibitor minzasolmin dissolved in SBECD for treatment of Parkinson disease

Direct targeting of alpha-synuclein (ASYN) has emerged as a disease-modifying strategy for Parkinson’s disease and other synucleinopathies which is being

Continue reading

September 5, 2023 Drug delivery / Pharma applications

Minzasolmin in SBECD solution for synuclein targeting in Parkinson disease treatment

Direct targeting of alpha-synuclein (ASYN) has emerged as a disease-modifying strategy for Parkinson’s disease and other synucleinopathies which is being

Continue reading

July 8, 2022 Drug delivery / Pharma applications

Lippia grata essential oil complexed with β-cyclodextrin ameliorates biochemical and behavioral deficits in an animal model of progressive parkinsonism

Parkinson’s disease (PD) is identified by the loss of dopaminergic neurons in the Substantia Nigra pars compacta (SNpc), and is

Continue reading

Recent Posts

  • Improving Drug Bioavailability with Cyclodextrin Complexes: An integrative meta-modeling approach
  • Coupling of opposite thermoresponsive mechanisms induced by host-guest complexation and LCST phase transition in formulations of modified hyaluronan and β-cyclodextrin copolymer
  • Targeted Codelivery of Doxorubicin and Carvacrol Nanogels
  • β-cyclodextrin-modified thermally oxidized biochar for efficient remediation of uranium-contaminated soil
  • Hydrogels for Cancer Immunotherapy

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (26)
  • Analysis (64)
  • CD as API (341)
  • CD derivatives (397)
  • Cosmetics and toilettry (49)
  • Diagnosis (12)
  • Drug delivery (777)
  • E-ducation (63)
  • Environmental (131)
  • Events (232)
  • Food (217)
  • Gene delivery (19)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (392)
  • Other industrial use (104)
  • Pharma applications (1,163)
  • Supramolecular systems (40)
  • Uncategorized (140)

Top Posts

  • Coupling of opposite thermoresponsive mechanisms induced by host-guest complexation and LCST phase transition in formulations of modified hyaluronan and β-cyclodextrin copolymer
  • How air fresheners work?
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • Antidote-like Effect of Cyclodextrins on Plant Neurotoxin Veratridine
  • Targeted Codelivery of Doxorubicin and Carvacrol Nanogels
  • Hydrogels for Cancer Immunotherapy
  • Extraction of mycotoxin alternariol from red wine and from tomato juice with beta-cyclodextrin bead polymer
  • Remdesivir dry powder inhalation formulation, pharmacokinetic study in hamsters
  • β-cyclodextrin complexes with propolis and royal jelly components
  • The revival of cyclodextrins as active pharmaceutical ingredients 

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,792 other subscribers
 

Loading Comments...